Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury A Follow-up Study of an International Randomised Controlled Trial
Phase of Trial: Phase III
Latest Information Update: 28 Aug 2018
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Traumatic brain injuries
- Focus Therapeutic Use
- 20 Aug 2018 Planned End Date changed from 30 Jun 2018 to 31 May 2019.
- 20 Aug 2018 Planned primary completion date changed from 31 Oct 2017 to 31 May 2019.
- 17 Aug 2017 Status changed from not yet recruiting to recruiting.